Original Article

You have full text access to this OnlineOpen article

Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population

  1. Sheryl G. A. Gabram MD1,2,†,*,
  2. Mary Jo B. Lund PhD1,2,3,4,
  3. Jessica Gardner BS1,
  4. Nadjo Hatchett CTR1,
  5. Harvey L. Bumpers MD5,
  6. Joel Okoli MD5,
  7. Monica Rizzo MD1,
  8. Barbara J. Johnson1,
  9. Gina B. Kirkpatrick MPH, MBA1,
  10. Otis W. Brawley2,4

Article first published online: 25 JUN 2008

DOI: 10.1002/cncr.23568

Issue

Cancer

Cancer

Volume 113, Issue 3, pages 602–607, 1 August 2008

Additional Information

How to Cite

Gabram, S. G. A., Lund, M. J. B., Gardner, J., Hatchett, N., Bumpers, H. L., Okoli, J., Rizzo, M., Johnson, B. J., Kirkpatrick, G. B. and Brawley, O. W. (2008), Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer, 113: 602–607. doi: 10.1002/cncr.23568

Author Information

  1. 1

    Georgia Cancer Center for Excellence at Grady Health System, Emory University School of Medicine, Atlanta, Georgia

  2. 2

    Winship Cancer Institute, Emory University, Atlanta, Georgia

  3. 3

    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia

  4. 4

    Department of Hematology/Oncology, Emory University, Atlanta, Georgia

  5. 5

    Georgia Cancer Center for Excellence at Grady Health System, Morehouse School of Medicine, Atlanta, Georgia

  1. †

    Fax: (404) 778-4255

*AVON Comprehensive Breast Center, Georgia Cancer Center for Excellence at Grady, Emory University School of Medicine, Winship Cancer Institute, 1365C Clifton Road, NE, Atlanta, GA 30322

Publication History

  1. Issue published online: 18 JUL 2008
  2. Article first published online: 25 JUN 2008
  3. Manuscript Accepted: 26 MAR 2008
  4. Manuscript Revised: 26 FEB 2008
  5. Manuscript Received: 5 NOV 2007

Funded by

  • AVON Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (130K)

REFERENCES

  • 1
    American Cancer Society. Cancer Prevention and Early Detection, Facts andFigures 2007. Atlanta, Ga: American Cancer Society; 2007.
  • 2
    Ries LAG,Eisner MP,Kosary CL, et al. SEER Cancer Statistics Review, 1975–2002. Bethesda, Md: National Cancer Institute; 2004. Available at: http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER website 2005. Accessed May 19, 2008.
  • 3
    Lund MJ,Brawley OP,Ward KC,Young JL,Gabram SS,Eley WJ. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2007 Jul 21 [Epub ahead of print].
  • 4
    Li CI,Malone KE,Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003; 163: 49–56.
  • 5
    Chu KC,Lamar CA,Freeman HP. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer. 2003; 97: 2853–2860.
    Direct Link:
  • 6
    Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin. 2000; 50: 50–64.
    Direct Link:
  • 7
    McWhorter WP,Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health. 1987; 77: 1515–1517.
  • 8
    Newman LA,Theriault R,Clendinnin N, et al. Treatment choices and response rates in African-American women with breast carcinoma. Cancer. 2003; 97( 1 suppl): 246–252.
    Direct Link:
  • 9
    Caplan LS,Helzlsouer KJ,Shapiro S, et al. System delay in breast cancer in whites and blacks. Am J Epidemiol. 1995; 142: 804–812.
  • 10
    Caplan LS,Helzlsouer KJ,Shapiro S,Wesley MN,Edwards BK. Reasons for delay in breast cancer diagnosis. Prev Med. 1996; 25: 218–224.
  • 11
    Dennis CR,Gardner B,Lim B. Analysis of survival and recurrence versus patient and doctor delay in treatment of breast cancer. Cancer. 1975; 35: 714–720.
    Direct Link:
  • 12
    Gwyn K,Bondy ML,Cohen DS, et al. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer. 2004; 100: 1595–1604.
    Direct Link:
  • 13
    Richards MA,Westcombe AM,Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review [see comment]. Lancet. 1999; 353: 1119–1126.
  • 14
    Gregorio DI,Cummings KM,Michalek A. Delay, stage of disease, and survival among white and black women with breast cancer. Am J Public Health. 1983; 73: 590–593.
  • 15
    Lannin DR,Mathews HF,Mitchell J, et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998; 279: 1801–1807.
  • 16
    Gates MF,Lackey NR,Brown G. Caring demands and delay in seeking care in African-American women newly diagnosed with breast cancer: an ethnographic, photographic study. Oncol Nurs Forum. 2001; 28: 529–537.
  • 17
    Li CI,Malone KE,Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev. 2002; 11: 601–607.
  • 18
    Bach PB,Schrag D,Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 2106–2113.
  • 19
    Hunter CP,Redmond CK,Chen VW, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993; 85: 1129–1137.
  • 20
    Eley JW,Hill HA,Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947–954.
  • 21
    West DW,Satariano WA,Ragland DR, et al. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996; 6: 413–419.
  • 22
    Yood MU,Johnson CC,Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999; 91: 1487–1491.
  • 23
    Jatoi I,Becher H,Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer. 2003; 98: 894–899.
    Direct Link:
  • 24
    Roetzheim RG,Gonzalez EC,Ferrante JM, et al. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000; 89: 2202–2213.
    Direct Link:
  • 25
    Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes [comment]. J Natl Cancer Inst. 2002; 94: 471–473.
  • 26
    Wojcik BE,Spinks MK,Optenberg SA. Breast carcinoma survival analysis for African-American and white women in an equal-access health care system. Cancer. 1998; 82: 1310–1318.
    Direct Link:
  • 27
    Chlebowski RT,Chen Z,Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005; 97: 439–448.
  • 28
    Newman LA,Mason J,Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002; 94: 2844–2854.
    Direct Link:
  • 29
    Newman LA,Griffith KA,Jatoi I, et al. Meta-analysis of survival in African-American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006; 24: 1342–1349.
  • 30
    Howard J,Hankey BF,Greenberg RS, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 1992; 69: 2349–2360.
    Direct Link:
  • 31
    Smith-Bindman R,Miglioretti DL,Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006; 144: 541–553.
  • 32
    Chu KC,Anderson WF. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat. 2002; 74: 199–211.
  • 33
    Chu KC,Anderson WF,Fritz A, et al. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for 8 racial/ethnic groups. Cancer. 2001; 92: 37–45.
    Direct Link:
  • 34
    Carey L,Perou C,Livasy C, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 2492–2502.
  • 35
    Jones BA,Kasl SV,Howe CL, et al. African-American/white differences in breast carcinoma: p53 alterations and other tumor characteristics [see comment]. Cancer. 2004; 101: 1293–1301.
    Direct Link:
  • 36
    Porter PL,Lund MJ,Lin MG, et al. Racial differences in expression of cell cycle regulatory proteins in breast cancer: study of young African-American and white women in Atlanta. Cancer. 2004; 100: 2533–2542.
    Direct Link:
  • 37
    Lund MJ,Eley JW,Liff JM, et al. Racial differences in triple negative breast tumors among women in Atlanta [oral presentation]. Presented at the 97th Annual Meeting of the American Association for Cancer Research, Washington, DC, April 2, 2006. Abstract LB-4.
  • 38
    Holmberg L,Ponten J,Adami HO. The biology and natural history of breast cancer from the screening perspective. World J Surg. 1989; 13: 25–30.
  • 39
    Gilliland FD,Joste N,Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers [comment]. J Natl Cancer Inst. 2000; 92: 743–749.
  • 40
    Royak-Schaler R,Rose DP. Mammography screening and breast cancer biology in African-American women—a review. Cancer Detect Prev. 2002; 26: 180–191.
  • 41
    Buist DS,Porter PL,Lehman C, et al. Factors contributing to mammography failure in women aged 40–49 years. J Natl Cancer Inst. 2004; 96: 1432–1440.
  • 42
    Mandelson MT,Oestreicher N,Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst. 2000; 92: 1081–1087.
  • 43
    Collett K,Stefansson IM,Eide J, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1108–1112.
  • 44
    Saslow D,Boetes C,Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 75–89.
    Direct Link:
  • 45
    Griggs JJ,Sorbero ME,Stark AT, et al. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003; 81: 21–31.
  • 46
    Finn RS,Dering J,Ginther C, et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro. Breast Cancer Res Treat. 2007; 105: 319–326.
  • 47
    Freeman HP,Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin North Am. 2005; 14: 655–669.
  • 48
    Dohan D,Schrag D. Using navigators to improve care of underserved patients. Cancer. 2005; 104: 848–855.
    Direct Link:
  • 49
    Rizzo M,Reisman N,Gabram S, et al. Differences in treatment in stage III breast cancer in African-American women [abstract]. J Clin Oncol. 2007; 25(pt I): 18S. Abstract 504.
  • 50
    Lund MJB,Gabram SGA,Hatchett N, et al. High prevalence of triple negative breast cancers among black women in an urban cancer center [abstract]. Presented at the 29th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, December 14–17, 2006. Breast Cancer Res Treat. 2006;100(suppl 1):S141. Abstract 3052.
View Full Article (HTML) Get PDF (130K)